Tai Chi for Stroke Rehabilitation on Balance and Cognition
Launched by CHUNGNAM NATIONAL UNIVERSITY · Aug 11, 2016
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Cerebrovascular disease is a major global concern. The individuals with stroke would suffer from disease associated symptoms which influence their functioning in everyday life. These symptom clusters were usually known to be sharing similar underlying mechanisms. It is clear that the development of effective stroke rehabilitation involves interdisciplinary team approach to manage physical, social, cognitive, and psychological functioning in this population.
Tai Chi, an ancient Chinese martial art, is a low intense aerobic exercise characterized by continuous movements that embrace the mind...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosed as stroke at least for 3 months upto 2 years
- • eligible to participate rehabilitation therapy referred by primary physician
- Exclusion Criteria:
- • not able to understand questionnaires
- • not able to stand alone for balance test
Trial Officials
Rhayun Song, PhD
Principal Investigator
Chungnam National University
About Chungnam National University
Chungnam National University is a prominent academic institution located in South Korea, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct innovative studies aimed at improving healthcare outcomes. With a focus on collaboration and scientific rigor, Chungnam National University fosters partnerships with various stakeholders, including healthcare professionals, researchers, and industry leaders, to explore cutting-edge therapies and interventions. Through its commitment to ethical standards and patient safety, the university plays a vital role in contributing to the global body of medical knowledge and enhancing the quality of life for individuals and communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Daejeon, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
